Evidence map›Paper›PMID 42558076›Full record

ArticleJournal of medical extended reality2024

Acceptance of Virtual Reality Among Adults with Rheumatologic Conditions.

Kimberly B Garza, Heqin Yang, Alexicia Richardson, Cheryl Seals, Gary Hawkins, Chad G Rose, Willliam B Nowell, Kelly Gavigan, Patrick Stewart, Liana Fraenkel and 1 more

Abstract read
In one paragraph

Article in Journal of medical extended reality, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Kimberly B GarzaAuburn University, Auburn, Alabama, USA.ORCID https://orcid.org/0000-0002-4684-372X
Heqin YangAuburn University, Auburn, Alabama, USA.
Alexicia RichardsonAuburn University, Auburn, Alabama, USA.
Cheryl SealsAuburn University, Auburn, Alabama, USA.
Gary HawkinsAuburn University, Auburn, Alabama, USA.
Chad G RoseAuburn University, Auburn, Alabama, USA.
Willliam B NowellGlobal Healthy Living Foundation, Upper Nyack, New York, USA.
Kelly GaviganGlobal Healthy Living Foundation, Upper Nyack, New York, USA.
Patrick StewartENRGY, Hoover, Alabama, USA.
Liana FraenkelBerkshire Medical Center, Pittsfield, Massachusetts, USA.
Jeffrey R CurtisENRGY, Hoover, Alabama, USA.

Funding

Methods and Health Informatics CoreP30AR072583 · NIAMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI JEFFREY R. CURTIS · 2020 to 2026
$5.7M
NIAMS NIH HHS P30 AR072583
6 · The paper itself

Abstract

Risk communication to patients with rheumatologic conditions is difficult. Virtual reality (VR) has demonstrated utility as a delivery mechanism for patient education, but user acceptance of this technology for applications such as communicating risks and benefits of health care interventions and medical treatments has been poorly studied. We aimed to assess the acceptability of VR as an educational tool among people with rheumatologic conditions and to compare acceptability among those who had used VR in the past to those who are VR naïve. A cross-sectional, web-based survey was conducted, sampling two populations: members of an online patient-powered research network (registry) that included adults with rheumatologic conditions, and patients within a large U.S. community rheumatology practice-based research network. Survey items included patient demographic and clinical characteristics, prior VR experience, perceived usefulness for learning about their condition, anticipated enjoyment, and willingness to use VR to manage disease. A total of 3927 individuals completed the survey. Overall, 14.9% reported having prior experience using VR, and of these, 54.0% had used it only one to two times. Twenty-nine percent of participants agreed that VR would be useful for learning about their condition (25.4% of VR naïve, 49.0% of VR experienced [

Indexed as

anticipated enjoymentperceived usefulnessrheumatologic conditionsvirtual realitywillingness to use

Identifiers

PMID42558076
PMCPMC13390694

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.